TMD — Titan Medical Balance Sheet
0.000.00%
Last trade - 00:00- CA$6.27m
- -CA$2.28m
- $17.63m
- 35
- 99
- 11
- 46
Annual balance sheet for Titan Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.814 | 25.5 | 32.3 | 3.29 | 7.54 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.084 | 0.072 | 8.28 | 0 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.75 | 26.9 | 43.7 | 5.04 | 8.66 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.03 | 1.11 | 1.64 | 0 | — |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 3.38 | 29.8 | 47.2 | 7.12 | 8.76 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.1 | 42.9 | 10.9 | 8.96 | 3.12 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 15.1 | 43.6 | 11.9 | 10.3 | 3.98 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -11.7 | -13.8 | 35.3 | -3.16 | 4.79 |
| Total Liabilities & Shareholders' Equity | 3.38 | 29.8 | 47.2 | 7.12 | 8.76 |
| Total Common Shares Outstanding |